← PLTR: big moves and long-term fundamentals中文

Palantir Technologies: The Long View

What the filings say about its story, dilution and cash runway.

Last updated Nov 3, 2026 · Reflects: 10-K for 2025 and the 10-Q for Q3 2026

Disclosure: one or more of our editors own shares of Palantir Technologies (PLTR) as a long-term investment. This page is information, not investment advice.

1. In one paragraph

Last updated Nov 3, 2026. Reflects the 10-K for 2025 and the 10-Q for Q3 2026.

Palantir sells subscriptions to software that pulls an organisation’s data into one working model of its operations, then lets staff and AI tools act on it. In 2025 revenue was $4.48B (+56%), split almost evenly between government and commercial customers (10-K 2025). Growth has since sped up: revenue rose 92% in the first nine months of 2026, to $5.88B (10-Q).

  • Its four platforms are Gotham (defence and intelligence), Foundry (data operations), AIP (Artificial Intelligence Platform, connecting large language models to that data; launched 2023) and Apollo (software delivery).
  • Revenue is mostly recognised evenly over contracts of one to five years, many of which customers can cancel.
  • It reports two segments:
2025 (disclosed) Revenue Share of total Growth
Government $2.40B 54% +53%
Commercial $2.07B 46% +60%
By customer location: United States / United Kingdom / rest of world $3.32B / $0.43B / $0.73B 74% / 10% / 16%

2. Story so far

Last updated Nov 3, 2026. Reflects filings and company releases through Nov 3, 2026.

In short: Palantir went public in 2020 as a loss-making software supplier to governments. It turned profitable under US accounting rules from late 2022, and according to its results, growth accelerated after the 2023 launch of its AI platform, led by US commercial and government customers. The share price has swung widely along the way, including a 48% fall between November 2025 and June 2026.

Date Milestone Source
Sep 30, 2020 Shares start trading on the NYSE through a direct listing 10-K 2020
2021 Invests in early-stage companies, many of them listed through special-purpose acquisition companies (SPACs, shell companies that raise money to merge with a business), alongside “strategic commercial contracts” with them. Revenue from those contracts later fell to $15.3M in 2025 10-K 2025
Feb 13, 2023 ★ Reports its first quarter of positive net income under US accounting rules (GAAP): $31M in Q4 2022 8-K
2023 ★ Begins deploying AIP, its generative-AI platform 10-Q Q2 2026
Aug 2023 Board authorises a $1.0B share buyback 10-K 2025
Sep 6, 2024 S&P Dow Jones Indices announces Palantir will join the S&P 500 (effective Sep 23) S&P DJI
Nov 26, 2024 Listing moves from the NYSE to Nasdaq 8-K
May 20, 2025 Army adds $795M to its Maven Smart System software-licence contract DoD contracts
Jul 31, 2025 ★ Army enterprise agreement: up to 10 years, a $10B ceiling (a maximum, not committed spending) Army
Nov 3, 2025 → Jun 25, 2026 Stock falls 48%, from a $207.18 close to $107.27. By Oct 26, 2026 it had recovered to $198.84, up 85% from the June close (our calculation)1, according to Stock Analysis Nasdaq price history, Stock Analysis
Jan 2026 Buyback programme terminated, after $139M spent in 2024–25 10-K 2025
Feb 2, 2026 First 2026 revenue guide: $7.182–7.198B 8-K
Mar 2026 Amends a cloud-hosting contract: at least $5.6B of spending over 10 years 10-Q Q1 2026
Aug 3, 2026 ★ Q2 2026 revenue +93%; 2026 guide raised to $8.150–8.158B. Stock +29.5% next day 8-K, Nasdaq
Oct 24, 2026 Start of our coverage: Palantir in our Big Picture article on AI listings WhyMyStockMoved
Nov 2, 2026 Q3 2026 revenue +96%; 2026 guide raised to $8.530–8.534B. Stock −1.6% next day 8-K, Nasdaq

3. Latest quarter: did the story change?

Last updated Nov 3, 2026. Reflects Q3 2026 (quarter to Sep 30): the results release, the 10-Q and the call.

Bottom line: Revenue growth sped up again and beat Palantir’s own forecast, but new contract signings slowed sharply. Q3 revenue grew 96%, about $149M above the top of its guide (our calculation)2, and management raised its full-year revenue and profit guidance for the third time this year; total contract value (TCV) grew 6% from a year earlier, after 49% in Q2. It was the 13th quarter in a row of faster year-on-year revenue growth, and the fastest since at least 2021 (our calculation)3. The stock fell 1.6% the next day, while the Nasdaq Composite rose 0.8%, according to Nasdaq and Yahoo Finance closes.

Driver Last quarter → this quarter Management: before → now Signal
Total revenue $1.935B (+93%) → $2.313B (+96%) 2026 revenue guide: $8.150–8.158B in August → $8.530–8.534B now; the Q3 guide was $2.160–2.164B Better
US commercial / US government revenue $764M / $809M → $984M (+148%) / $953M (+96%); commercial exceeded government for the first time, by the company’s account 2026 US commercial guide: more than $3.424B in August → more than $3.559B now; no government guide Better
International revenue (our calculation)4 $362M → $376M (+26% from Q3 2025) No guide → no guide (+4% from Q2) Unchanged
Contract signings (TCV) $3.373B (+49%) → $2.918B (+6%); US commercial $2.132B (+153%) → $1.463B (+11%) No guide → no guide; the CFO says several large deals were shorter than usual and expects length and size to grow Worse
Profit margins and costs GAAP operating margin 47% → 47%; adjusted 62% → 62% Q3 adjusted operating income guide $1.292–1.296B → actual $1.427B; 2026 guide $4.889–4.897B in August → $5.245–5.249B now Better

Sources: Q2 2026 release, Q3 2026 release, Q3 2025 release, 10-Q. “Adjusted” excludes stock-based pay and related payroll taxes (company definition). TCV and remaining deal value assume customers exercise every option and do not cancel; most contracts can be terminated, the company says.

Management’s explanation for slower signings is contract length, but it did not say how much of the slowdown that accounts for. CFO Dave Glazer said Palantir signed “multiple eight-figure deals in the quarter that were shorter in duration than usual,” and that he expects both duration and size to increase over time (call transcript). Over 12 months, US commercial TCV was still up 62%, to $6.114B, he said. Sanjit Singh, a Morgan Stanley analyst (Equal Weight), raised his price target to $233 from $205 and linked the muted share reaction to higher US commercial expectations and slower bookings, The Fly reported (TipRanks).

Costs came in about as management warned. In August the CFO said adjusted expenses would rise significantly in Q3 (call transcript); they rose 20%, to $887M, and revenue rose about as fast, which left the adjusted margin at 62% (call transcript).

Unresolved questions: whether contracts lengthen as management expects; whether international growth picks up; what Palantir’s first 2027 guidance assumes.

4. Buybacks vs real dilution (5 years)

Last updated Nov 3, 2026. Reflects the equity statements in the 10-Ks for 2022 and 2025 and the 10-Q Q3 2026.

Dilution in one line: From Dec 31, 2020 to Dec 31, 2025 the share count (all classes) rose 33.4%, about 5.9% a year compounded (our calculation)5. If you owned 1% of Palantir at the end of 2020, you’d own about 0.75% at the end of 2025 without buying more (our calculation)6. Buybacks offset about 0.45% of the new shares (our calculation)7. Almost all new shares came from employee stock awards. Our scale: High (over 3% a year).

Our rule of thumb: under 1% a year low, 1–3% moderate, over 3% high.

Change in shares outstanding, Dec 31, 2020 to Dec 31, 2025FY2021 +13.1%, FY2022 +3.5%, FY2023 +4.8%, FY2024 +6.3%, FY2025 +2.2%. Total +33.4% since Dec 31, 2020.0%+10%+20%+30%+40%FY2021: +13.1% in the period; +13.1% since Dec 31, 2020+13.1%FY2021FY2022: +3.5% in the period; +17.1% since Dec 31, 2020+3.5%FY2022FY2023: +4.8% in the period; +22.8% since Dec 31, 2020+4.8%FY2023FY2024: +6.3% in the period; +30.5% since Dec 31, 2020+6.3%FY2024FY2025: +2.2% in the period; +33.4% since Dec 31, 2020+2.2%FY2025+33.4%since Dec 31, 2020

Change in the period Total since Dec 31, 2020

Shares outstanding at period end (all classes): 1.79B on Dec 31, 2020, 2.39B on Dec 31, 2025, +33.4% (our calculation). A bar below zero means the count fell (net buybacks).

Latest quarter-end (Jun 30, 2026): 2.40B shares, +0.5% since Dec 31, 2025.

All classes (Class A, B and F).

Period endShares outstandingChangeBuybacks (fiscal year)Stock-based pay (fiscal year)Stock pay as % of revenue
FY2025 (Dec 31, 2025)2.39B+2.2%$75M$684M15%
FY2024 (Dec 31, 2024)2.34B+6.3%$64M$692M24%
FY2023 (Dec 31, 2023)2.20B+4.8%$0$476M21%
FY2022 (Dec 31, 2022)2.10B+3.5%$0$565M30%
FY2021 (Dec 31, 2021)2.03B+13.1%$0$778M50%
FY2020 (Dec 31, 2020)1.79B—$4M$1.3B116%

Shares outstanding from the balance sheets in the company's 10-K and 10-Q filings; buybacks (cash spent) and stock-based pay from its 10-Ks, via SEC EDGAR.

How we calculated this
Share bridge, Dec 31, 2020 → Dec 31, 2025 (our calculation from disclosed equity statements; millions) Shares
Start (all classes) 1,792.1
+ Stock options exercised +369.6
+ Restricted stock units (awards settled in shares after vesting conditions are met) released, including growth units (another equity award) +221.5
+ Stock appreciation rights (awards based on increases above a specified share price) settled in 2024, net of shares withheld for employee taxes +5.9
+ Warrants and other (2021) +4.7
− Shares repurchased (2024–25; $139.2M spent) −2.7
End 2,391.2 (+33.4%)
Shares issued for acquisitions, convertibles or offerings None in the period

Totals use unrounded filing figures; the displayed components may not sum exactly because of rounding. Gross issuance was 601.776M shares and repurchases 2.724M.

Prices paid and received:

Period Shares bought back Average price paid Spent Shares sold for cash Average price received Raised Sources
2021 — — — — — — 10-K 2022 equity statement
2022 — — — — — — 10-K 2022 equity statement
2023 — — — — — — 10-K 2025 equity statement
2024 2.12M $30.24 (our calculation) $64.2M — — — 10-K 2025 equity statement and cash-flow statement
2025 0.60M $124.88 (our calculation) $75.0M — — — 10-K 2025, Item 5: 600,446 shares; equity statement: $74.985M spent8
2026 YTD (to Sep 30) 0.008M about $188 (our calculation; inputs rounded to thousands) $1.5M — — — 10-Q Q3 2026 equity statement (bought in January; the programme was terminated that month per the 10-K 2025)

Palantir bought back little (about $139M over 2024–25) and sold no shares for cash, so the prices it paid are the only prices to compare.

  • Average price paid is our calculation9.
  • Palantir has not split its stock, so all figures are as reported.
  • Buybacks exclude shares withheld for employee taxes ($218.3M in 2024, $81.1M in 2025), which the company reports separately and does not count as repurchases.
  • Palantir sold no shares for cash, through offerings or at-the-market programmes, in 2021 through the first nine months of 2026; proceeds from employee option exercises are excluded.
  • For reference, the stock closed at $175.40 on Nov 3, 2026 (Nasdaq).
Diluted shares and stock pay (disclosed; % is our calculation) 2021 2022 2023 2024 2025 9M 2026
Weighted diluted shares (M)* 1,923.6 2,063.8 2,297.9 2,450.8 2,565.2 2,571.2
Stock-based pay ($M) 778.2 564.8 475.9 691.6 684.0 785.7
Stock pay as % of revenue10 50% 30% 21% 24% 15% 13%

*Loss years (2021–22) show no dilution from awards, so diluted shares equal basic.

Buybacks of $139M compare with $3.19B of stock-based pay over 2021–25 (our calculation)11; awards still outstanding could add more shares.

Share count and outstanding awards
  • At Sep 30, 2026, 2,409.2M shares were outstanding.
  • Awards still outstanding at that date were 146.8M options (average exercise price $10.16), 35.6M restricted units (including performance units) and 18.5M stock appreciation rights (10-Q).
  • Palantir also paid $218.3M (2024) and $81.1M (2025) in employee taxes, so that it could withhold shares instead of issuing them (10-K 2025).

5. Profit vs cash (latest FY and TTM)

Last updated Nov 3, 2026. Reflects the 10-K 2025, the Q3 2025 and Q3 2026 releases and the 10-Q Q3 2026. TTM = the four quarters to Sep 30, 2026 (our calculation)12.

Cash generation is close to adjusted profit and above GAAP net income. Stock-based pay is a non-cash expense added back in operating cash flow, customer prepayments supported cash flow, and rising receivables reduced it.

$M 2025 (disclosed unless marked otherwise) TTM (our calculation)
Net income attributable to common stockholders 1,625.0 3,669.1
Adjusted operating income (company’s reconciliation: GAAP operating income + stock pay + employer payroll taxes on stock pay) 2,254.1 4,403.3
Operating cash flow 2,134.5 4,097.2
Capital spending 33.9 43.2
Free cash flow (our calculation)13 2,100.6 4,054.0
Company’s “adjusted free cash flow” (adds back cash payroll taxes on stock pay) 2,270.4 4,152.5

Helps future profit or cash:

  • Receivables (−$450.4M in 2025): growth in amounts owed by customers reduced operating cash flow. Collection would bring in cash; billing and revenue recognition can occur at different times.
  • Contract liabilities (+$238.7M in 2025): the cash-flow statement records a benefit from deferred revenue and customer deposits. Amounts already collected generally produce revenue without another customer payment when services are delivered; some deposits are refundable if contracts are cancelled.
  • A very low tax rate (1.3% in the first nine months of 2026, our calculation) lowers the tax on GAAP profit and so the profit and cash kept; Palantir holds $9.0B of federal tax-loss carryforwards and a full valuation allowance (a reduction in recorded deferred tax benefits because their future use is uncertain) on its US and UK deferred tax assets.

Hurts future profit or cash:

  • Stock-based pay (+$684.0M added back in 2025): an expense paid in shares, so it adds no cash outflow but dilutes ownership; the related payroll taxes and share withholding cost cash (sections 4 and 5).

One-off / no lasting effect:

  • $37.2M of 2025 revenue paid in securities rather than cash: in profit, not in operating cash.
  • $35.0M of realized and unrealized gains on marketable securities deducted in the first nine months of 2026: in profit, not in operating cash.
The raw reconciling items

From the filings:

  • Stock pay added back $684.0M in 2025 ($982.1M TTM). The accounting expense is non-cash; the related cash costs (payroll taxes, tax withholding) are reported separately (sections 4 and 5).
  • Rising receivables took away $450.4M in 2025 ($870.9M TTM), as amounts billed but not yet collected grew with revenue. Receivables were $1.88B at Sep 30, 2026.
  • Contract liabilities (customer prepayments) added $238.7M in 2025 ($475.5M TTM).
  • In 2025, $37.2M of revenue was paid in securities rather than cash; in the first nine months of 2026, the operating cash-flow reconciliation deducted $35.0M of realized and unrealized gains on marketable securities.
  • GAAP profit also benefits from a very low tax rate (1.3% in the first nine months of 2026, our calculation from the 10-Q). At Dec 31, 2025, Palantir reported a $3.5B valuation allowance against deferred tax assets (a reduction in recorded tax benefits because their future use is uncertain), a full allowance on its US and UK tax assets, and $9.0B of federal tax-loss carryforwards (10-K).
Self-funding

Funding: how long without new money? Self-funding: about $4.05B of free cash flow in the 12 months to Sep 30, 2026 (our calculation)14; no debt is due, against about $10.38B of cash and US Treasuries.

Funding details
  • As of Sep 30, 2026. Based on past cash flow; spending plans can change it.
  • Cash, cash equivalents and marketable debt securities: $10,376.1M15. This excludes $185.4M of listed equity stakes held within marketable securities (10-Q).
  • Debt and convertible notes due within 24 months: none (no debt outstanding).
  • At-the-market share-sale programme: none disclosed.

Extends the runway:

  • A $500M revolving credit facility, undrawn at Sep 30, 2026, which is committed money Palantir can draw until it matures on Mar 31, 2027.

Shortens the runway:

  • No debt principal maturities or cash earn-outs are disclosed. The undrawn credit facility requires at least $50M of liquidity and contains other financial and operating restrictions; Palantir reported compliance at Sep 30, 2026.

Conditional:

  • None disclosed.

6. Customer and contract exposure

Last updated Nov 3, 2026. Reflects the 10-K 2025, the 10-Q Q3 2026 and the Q3 call.

Revenue is spread across many customers, but government business and the largest accounts matter: government is about half of revenue and the 20 largest customers roughly 40%.

Palantir customer concentration
Government customers, first nine months of 2026: 51% of revenueGovernment customers, first n…51%20 largest customers, 12 months to Sep 30, 2026: 40% of revenue20 largest customers, 12 mont…40%3 largest customers, first nine months of 2026: 16% of revenue3 largest customers, first ni…16%Largest customer’s share of receivables, Sep 30, 2026: 27% of receivablesLargest customer’s share of r…27%
Show the data
Label Value Unit
Government customers, first nine months of 2026 51 % of revenue
20 largest customers, 12 months to Sep 30, 2026 40 % of revenue
3 largest customers, first nine months of 2026 16 % of revenue
Largest customer’s share of receivables, Sep 30, 2026 27 % of receivables

Chart source16.

Customer and contract details
  • Palantir reported no customer at 10% or more of revenue in 2024–25, and none above 10% in the first nine months of 2026. The top three were 16% of revenue in the first nine months of 2026 and in 2025 (17% in 2024). It had 1,090 customers at Sep 30, 2026, up from 911 a year earlier. Disclosed.
  • The top 20 customers averaged $146M each in the 12 months to Sep 30, 2026, up 76%, about 40% of TTM revenue (our calculation)17.
  • One unnamed customer (“Customer I”) was 27% of receivables at Sep 30, 2026, up from 25% at Dec 31, 2025. Disclosed.
  • Government customers were 51% of revenue in the first nine months of 2026. The US government was $953M, or 41% of Q3 revenue (our calculation)18. Palantir says the Federal Acquisition Streamlining Act (FASA), which favours commercial products in US government procurement, has “resulted in a significant increase” in its federal business.
  • Many contracts can be cancelled for convenience on less than 12 months’ notice. Reported remaining performance obligations (RPO) were $4.9B, with about 44% expected within 12 months. This excludes cancellable revenue and contracts originally lasting 12 months or less. Disclosed.
  • The cloud provider behind the $5.6B 10-year minimum (to Feb 2036) is not named.
Key contract Signed Term Size Note
US Army enterprise agreement Jul 31, 2025 Up to 10 years Up to $10B ceiling Combines 75 contracts; other Defense Department units can buy under it (Army)
TITAN ground stations (Army) Production orders as of Aug 31, 2026 Not disclosed $127M to Palantir, of $192M for eight initial systems; Anduril got $65M Army
Maven Smart System licences (Army) May 20, 2025 modification Estimated completion May 28, 2029 +$795M DoD
NHS England Federated Data Platform (Palantir-led consortium) Nov 2023 Up to 7 years Up to £330M across the consortium The contract has an early 2027 break clause, which Parliament’s Science, Innovation and Technology Committee recommended exercising in its June 3, 2026 report. The government must decide on an extension by December 2026, the House of Commons Library says. Scope per NHS England
France DGSI (domestic intelligence) Renewal announced Dec 15, 2025 (company release) Three years Not disclosed On Jun 16, 2026, France’s prime minister announced plans for ChapsVision to replace Palantir at the DGSI. Palantir said its contract remained fully in force, Euronews reported (Euronews)

7. Palantir’s strategy for long-term growth

Last updated Nov 3, 2026. Reflects the 10-K for 2025, the Q3 2026 release and 10-Q, and the Q3 call.

Palantir wants to be the layer organisations use to run AI on their own data and workflows, rather than relying on a model supplier’s finished product. So far the numbers support that in the US, much less outside it, and Palantir does not report its AI products’ revenue separately.

Pressure on the core business

The main rival is still a customer’s own IT team, and growth is concentrated in one country.

  • Palantir says it is “fundamentally competing with the internal software development efforts of our potential customers,” alongside large enterprise software companies, government contractors and system integrators (10-K).
  • AI model suppliers are the newer argument. CTO Shyam Sankar said “the conceit that the labs have wrong” is treating the individual knowledge worker, rather than the workflow, as the basic unit of a business (call).
  • Countries outside the US supplied 16% of Q3 revenue, down from 25% a year earlier (10-Q).
  • Many contracts can be cancelled, and two government contracts abroad are politically contested (section 6).

The strategy in management’s words

  • AI on the customer’s workflows: “Palantir is obsessed with turning tokens into economic value,” Sankar said, calling its AIP platform “a harness for the enterprise” (call).
  • Sovereign AI: this newer offering has customers fine-tune open-weight AI models (models whose settings are publicly available) on their own data inside Palantir’s software. CEO Alex Karp calls the moment “purpose-built for Palantir” (Q3 release). Glazer described it as “only one quarter old” (call).
  • Start small, then expand: Chief Revenue Officer Ryan Taylor said an industrial materials customer piloted a nearly $3M engagement in Q2, then signed a deal worth $29M a year (call). These are the company’s own examples.
  • Spending ahead of growth: adjusted expenses rose 53% from a year earlier, driven mainly by AI platform investment and technical hiring, Glazer said (call). Palantir has also committed at least $5.6B to one cloud provider over 10 years (10-Q).
  • Deals and past attempts: no shares were issued for acquisitions in the five years to 2025 (section 4). The 2021 investments in early-stage companies, paired with commercial contracts worth $326M in total, are winding down: about $400,000 of revenue in Q3, and none expected after Q4. Palantir does not expect new SPAC investment agreements (10-Q; call).

Is it working?

In the US, yes on revenue, with signings the open question. Outside the US, less so.

  • US commercial revenue grew 148% to $984M, and US commercial customers grew 29% to 686 (call).
  • Net dollar retention, which measures how much more existing customers spend than a year earlier, was 165%, up 8 points from Q2 (call).
  • International commercial revenue was $184M, up 21% from a year earlier but only 1% from Q2 (call).
  • The yardstick Palantir gives is its annual guidance: the 2026 revenue guide has risen from $7.182–7.198B in February to $8.530–8.534B (February release; Q3 release).
  • Not disclosed: revenue from AIP or Sovereign AI, or how much of the slowdown in signings comes from shorter contracts.
  • Morgan Stanley’s Singh raised his 2027 forecasts to 65% revenue growth from 45%, and to a 63.5% operating margin from 61%, while keeping his Equal Weight rating, TipRanks reported (TipRanks).

What to watch

Whether contracts lengthen as management expects, whether growth outside the US picks up, and what the first 2027 guidance assumes (section 8).

8. What to watch

Last updated Nov 3, 2026. Reflects the Q3 2026 10-Q, the Q3 release and company announcements through Nov 3, 2026.

Date Item Source
Dec 2026 The UK government must decide whether to extend the NHS Federated Data Platform contract, with the initial term ending in March 2027, the House of Commons Library says. We found no decision announced as of Nov 3. A parliamentary committee recommended using the early 2027 break clause Commons Library, Committee report
Dec 11, 2026 US government stopgap funding expires. Fiscal 2027 defence appropriations are still pending, SpacePolicyOnline reported SpacePolicyOnline
Dec 12, 2026 Scheduled end of CEO Alex Karp’s conditional trading plan, which covers potential sales of up to 7.08M shares and can end earlier 10-Q Q1 2026
Feb 2027 (expected) Q4 results (company guide: revenue of $2.649–2.653B), the 2026 annual report and first 2027 guidance Q3 release
Mar 31, 2027 The $500M credit facility, undrawn at Sep 30, 2026, matures 10-Q
May 11, 2027 Latest end of CTO Shyam Sankar’s conditional trading plan, adopted in August, which covers potential sales of up to 1.45M shares 10-Q
Date not set A 2022 securities class action was dismissed in 2025, and the appeal was heard on Mar 16, 2026. The Q3 10-Q reports no ruling 10-Q

Valuation at each update

At the close used for each update, from the filings available then. Frozen when the update is published; never revised.

UpdateCloseMarket valueEVP/SEV/salesP/EP/FCFRevenue growthFCF marginNet cash (debt)Basis
Oct 27, 2026$198.84 (Oct 26)$477.8B$468.4B77.6×76.1×158.4×142.3×+79%55%$9.4B12 months to Jun 30, 2026
Nov 3, 2026$175.40 (Nov 3)$422.6B$412.2B58.0×56.6×115.2×104.3×+87%56%$10.4B12 months to Sep 30, 2026

Our calculation from each update's filings (latest at the newest update: 10-Q for the quarter to Sep 30, 2026, filed Nov 3, 2026); not investment advice. n/m = not meaningful (e.g. negative earnings). Hover a heading for its definition. Oct 27, 2026 price: the Long View's stated close (Stock Analysis). Nov 3, 2026 price: Nasdaq historical close.

Notes and calculations

  1. $198.84 ÷ $107.27 − 1. ↩

  2. $2,313.411M Q3 revenue − $2,164M top of the Q3 guide = $149.411M. ↩

  3. Year-on-year revenue growth by quarter, from Palantir’s 10-Q/10-K revenue (Q4 = full year − nine months): 13% in Q2 2023, then 17%, 20%, 21%, 27%, 30%, 36%, 39%, 48%, 63%, 70%, 85%, 93% and 96% in Q3 2026. The highest earlier quarter in the data (from Q1 2021) is 49%. ↩

  4. Total − US. ↩

  5. Change = 2,391.192 ÷ 1,792.140 − 1; annual rate = (2,391.192 ÷ 1,792.140)^(1/5) − 1. ↩

  6. 1% × 1,792.1M ÷ 2,391.2M. ↩

  7. 2.724M shares repurchased ÷ 601.776M shares issued ≈ 0.45%. ↩

  8. $74,985,000 ÷ 600,446 = $124.88. ↩

  9. $ spent ÷ shares bought back. ↩

  10. Stock pay ÷ revenue. ↩

  11. Sum of the yearly figures above. ↩

  12. 2025 + first nine months of 2026 − first nine months of 2025. ↩

  13. Operating cash flow − capital spending. ↩

  14. Operating cash flow − capital spending, 12 months to Sep 30, 2026 (table above). ↩

  15. $3,619.4M cash + $6,942.1M marketable securities − $185.4M listed equity securities. ↩

  16. Palantir 10-K 2025 and 10-Q Q3 2026 (customer concentration, receivables); the 20-largest and US-government shares are our calculation (notes 13 and 14). ↩

  17. 20 × $146M ÷ $7.29B TTM revenue ≈ 40%. ↩

  18. $953M ÷ $2,313M. ↩

Quoting this? You may quote short excerpts under our reuse policy. Please credit WhyMyStockMoved.com and link to this page.

About Palantir Technologies: Website (external site)Investor relations (external site)SEC filings (external site)Wikipedia (external site)